Literature DB >> 31914867

Expectant management of retained abnormally adherent placenta complicated by uterine prolapse after vaginal delivery.

Nnabuike C Ngene1, Amon Siveregi2.   

Abstract

The placenta accreta spectrum (PAS) describes invasion and adherence of the placenta onto or beyond the myometrium. Prenatal imaging improves management outcomes. In low- and middle-income countries (LMIC), however, the unavailability of ultrasonography in some health facilities delays the diagnosis, particularly if the prenatal period is asymptomatic. Following vaginal delivery, it often manifests as failure to remove a retained placenta manually. In the absence of haemorrhage, expectant management involving leaving the placenta in situ, is an option. In the presence of haemorrhage and/or sepsis, hysterectomy is usually recommended. We present a case of an expectantly managed PAS following a spontaneous preterm vaginal birth. The patient developed puerperal uterine prolapse with the placenta in situ, a previously unreported complication, but this was successfully reduced manually.

Entities:  

Keywords:  Placenta accreta spectrum; placenta increta; preterm prelabour rupture of membranes; puerperal uterine prolapse; retained placenta

Year:  2020        PMID: 31914867     DOI: 10.1177/0049475519898557

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  2 in total

1.  Late abdominal pregnancy in a post-conflict context: case of a mistaken acute abdomen - a case report.

Authors:  Justin Lussy Paluku; Benjamin Kambale Kalole; Cathy Mufungizi Furaha; Eugenie Mukekulu Kamabu; Gaspard Makambo Mohilo; Benjamin Kasereka Kataliko; Susan Andrea Bartels
Journal:  BMC Pregnancy Childbirth       Date:  2020-04-22       Impact factor: 3.007

2.  Childbirth resulting in traumatic stretching and prolapsing of the anterior lip of the cervix outside the vagina: A case report.

Authors:  Ogbonnaya Orji; Nnabuike Chibuoke Ngene
Journal:  Case Rep Womens Health       Date:  2022-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.